Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study on Third-line Treatment of Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With Sindillimab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05810142
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:13.668895+00:00
Published At
2023-04-12T00:00:00+00:00
Record Updated At
2023-04-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Third-line Treatment", "Dvanced Duodenal Adenocarcinoma", "Furquinelone Combined With Sintilimab"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-04-12"
protocolSection.identificationModule.nctId
"NCT05810142"
protocolSection.identificationModule.officialTitle
"Clinical Study on Third-line Treatment of Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With Sindillimab"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Third-line Treatment (protocolSection.conditionsModule.conditions)
  • Dvanced Duodenal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Furquinelone Combined With Sintilimab (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.